Scientists leverage machine learning and AI to guide vaccine development

From tackling homework challenges to drafting emails, people are discovering a vast array of applications for natural language processing tools like generative artificial intelligence (AI) engines.

DNA test that predicts opioid addiction should be pulled off the market, critics urge the FDA

In the next 24 hours, more than 130 people will die from opioid-related drug overdoses. That will happen again tomorrow and the next day. Each

April 4, 2024

RP-3 by Replimune for Head And Neck Cancer: Likelihood of Approval

RP-3 is under clinical development by Replimune and currently in Phase I for Head And Neck Cancer.

November 18, 2023

Apollomics plans to lay off staff, narrow focus for lung cancer trial

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

July 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.